| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 36,339 | 33,455 | 41,898 | 46,594 |
| Excise taxes | - | - | 9,636 | 12,330 |
| Net revenue | - | - | 32,262 | 34,264 |
| Cost of sales | 17,501 | 18,865 | 18,528 | 30,341 |
| Inventory write-down | 506 | 86 | - | 312 |
| Gross profit | 18,332 | 14,504 | 13,734 | 3,611 |
| Sales and marketing | 5,301 | 5,347 | 4,565 | 5,528 |
| Research and development | 1,345 | 929 | 793 | 1,242 |
| General and administrative | 9,254 | 10,536 | 9,309 | 12,760 |
| Restructuring costs | 212 | 768 | 555 | - |
| Share-based compensation | 2,333 | 1,381 | 2,088 | 2,262 |
| Depreciation and amortization | 354 | 867 | 496 | 1,098 |
| Impairment loss on long-lived assets | 36 | 0 | - | 14,376 |
| Total operating expenses | 18,835 | 19,828 | 17,806 | 37,266 |
| Operating loss | -503 | -5,324 | -4,072 | -33,655 |
| Interest income, net | 11,742 | 8,997 | 9,665 | 12,460 |
| Share of income from equity method investments | 0 | 0 | - | - |
| Gain on revaluation of loan receivable | 0 | - | - | 11,804 |
| Gain on revaluation of equity method investment | 0 | - | - | 32,469 |
| Gain (loss) on revaluation of financial instruments | 4,066 | -640 | 49 | -293 |
| Impairment loss on other investments | 0 | 0 | - | - |
| Foreign currency gain (loss) | 19,785 | -39,538 | 1,583 | -7,432 |
| Loss on held-for-sale assets | 3,031 | 2,501 | - | 10,422 |
| Change in allowance for credit loss on non-operating loan | -4,771 | - | - | - |
| Other, net | -283 | -1 | 43 | -315 |
| Total other income | 27,508 | -33,683 | 11,340 | 38,271 |
| Income (loss) before income taxes | 27,005 | -39,007 | 7,268 | 4,616 |
| Income tax benefit | -1,316 | -525 | -455 | -2,708 |
| Income (loss) from continuing operations | - | - | - | 7,324 |
| Net income (loss) | 28,321 | -38,482 | 7,723 | 7,324 |
| Net income (loss) attributable to non-controlling interest | 2,363 | 1,229 | 1,601 | -1,025 |
| Net income (loss) attributable to cronos group | 25,958 | -39,711 | 6,122 | 8,349 |
| Basic net income (loss) per share attributable to cronos group (in dollars per share) | 0.07 | -0.1 | 0.02 | 0.02 |
| Diluted net income (loss) per share attributable to cronos group (in dollars per share) | 0.07 | -0.1 | 0.02 | 0.02 |
| Weighted-average number of common shares for computation of diluted income (loss) from continuing operations per share (in shares) | 384,992,713 | 385,306,213 | 386,963,685 | 385,984,407 |
| Weighted-average number of common shares outstanding for computation for basic income (loss) per share (in shares) | 383,086,739 | 385,306,213 | 382,958,797 | 382,285,589 |
Cronos Group Inc. (CRON)
Cronos Group Inc. (CRON)